Pregnant women's needs regarding the Tdap vaccine: Insights from Reddit discussions

Soojung Jo1, Tatiana R Ringenberg2, Jon W Hurley3

  • 1School of Nursing, Purdue University, West Lafayette, Indiana, United States of America.

Tdap vaccination during pregnancy is essential to protect the fetus, yet the vaccination rate in the United States remains suboptimal. Little is known about pregnant women's perspectives or the factors that influence their Tdap vaccination decisions. Given that many pregnant women turn to social media and online sources for health information, this study aims to analyze social media posts from Reddit to better understand the needs of pregnant women regarding the maternal Tdap vaccine. This qualitative study analyzed the posts from Reddit collected from October 2020-2023. After screening, 86 posts were included for analysis. Thematic analysis was conducted. Four key themes emerged: information seeking, vaccine hesitancy, regulation and public policy, and concerns related to contact with newborns. Pregnant women actively sought information to clarify concerns and better understand healthcare providers' advice. Some reported a lack of vaccine recommendations from providers, and inconsistent recommendations for the vaccination timing by the providers. Vaccine hesitancy and refusal were also expressed. In addition, confusion arose around policies recommending Tdap for family members and close contacts, leading to interpersonal conflict and resistance. Many posts described pushback from family members. Pregnant women face multifaceted needs and challenges related to vaccine information, policies, and emotional support. Healthcare providers should initiate the vaccine recommendation with clear information, considering the patients' literacy and address concerns. Additionally, public health agencies and professional organizations should prioritize promoting the maternal Tdap vaccine by supporting access, including cost coverage.

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Vaccinations01:51

Vaccinations

Overview
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Therapeutic Drug Monitoring: Affecting Factors01:29

Therapeutic Drug Monitoring: Affecting Factors

Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.